Is the hantavirus outbreak similar to COVID 19? WHO chief outlines 3 major differences

Concerns around the hantavirus outbreak linked to the MV Hondius cruise ship have raised comparisons with COVID 19. Here's ...

COVID-19 in Sask: ICU count hits recent low, 2 more cases of P1 variant found

The number of Saskatchewan COVID-19 patients under intensive care is at its lowest point in nearly a month. On Thursday, health officials reported 38 people in ICUs across the province, which is down ...

Why hantavirus is not like COVID, according to infectious disease experts

Infectious disease experts have sought to reassure people that the hantavirus cruise ship outbreak poses very low risks to ...

A common mutation linked to autoimmune diseases may protect people from viral infections

New research from the University of Kansas shows a "risk gene" linked to higher odds of developing autoimmune diseases such ...

Fewer Albertans dying due to COVID-19, statistics show. But experts warn the risk isn’t gone

Alberta’s COVID-19 death toll continues to decline. While the trend is positive news, experts warn most of these deaths are ...

Hantavirus—How It’s Different From COVID-19 And The U.S. Response

Will Hantavirus cause the next pandemic? A public health expert explains why it is unlikely to result in a global pandemic, ...

Canine coronavirus: Can the infection in dogs spread to humans easily?

Canine coronavirus primarily affects dogs, but emerging research suggests possible human infection risks. Here's what experts ...

Acting CDC Director Jay Bhattacharya Called A Vaccine Study Design 'Crap.' What The Test-Negative Design Is And How We Know Whether Vaccines Measured With It Are Effective

Jay Bhattacharya dismissed the test-negative design as 'crap.' The biostatistics literature tells a different story.

Hantavirus asymptomatic case raises questions for health experts

Health officials confirmed one American has tested positive for the virus while asymptomatic, while another is showing ...
Medical News Today

Is hantavirus the next global threat? Fact-checking the outbreak with experts

As efforts to contain the Andes hantavirus outbreak aboard the MV Hondius is underway, Medical News Today speaks to medical ...
The Manila Times

Invivyd and Collaborators Author New Manuscript Evaluating Early Tolerability of COVID Monoclonal Antibody and Comparing Results to COVID Vaccination

Invivyd authors evaluated early side effects of prior low-dose investigational monoclonal antibody adintrevimab from the EVADE study, demonstrating minimal tolerability issuesResults allow for ...